Details of HTA journal title
Last updated: 5 August 2008 - Next update due: 12 August 2008
Research type: |
NICE Technology Assessment Report (TAR) |
Title (lead author) etc: |
The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation (review of NICE Guidance No. 33) (Hind) 182 pages, Volume 12, number 15 |
Link to NICE guidance page |
|
View/print executive summary
View/print abstract
View full text in pdf format (1835 KB)
Go to our correspondence page to comment on this publication
|
|
Project ref: |
04/12/01 |
Original project title: |
The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation (review of NICE Guidance No. 33) |
Chief Investigator: |
School of Health and Related Research (ScHARR-TAG), University of Sheffield |
Start Date: |
August 2004. |
Publication date: |
May 2008 |
Cost: |
This project was commissioned by the HTA programme on behalf of the National Institute for Health and Clinical Excellence on a call-off contract basis |
MeSH* index primary terms: |
COLORECTAL-NEOPLASMS Q-drug-therapy; ANTINEOPLASTIC-COMBINED-CHEMOTHERAPY-PROTOCOLS Q-therapeutic-use (* = Medical Subject Headings) |
MeSH* index secondary terms: |
HUMAN; QUALITY-OF-LIFE; IRINOTECAN Q-administration-&-dosage; RALTITREXED Q-administration-&-dosage; OXALIPLATIN Q-administration-&-dosage; COST-BENEFIT-ANALYSIS; TECHNOLOGY-ASSESSMENT-BIOMEDICAL (* = Medical Subject Headings) |
NRR* number, if applicable: |
N0484149105 (*National Research Register) |
Project Protocol: |
Project protocol not available |
Printed copies of this title despatched: |
96 (Figures relate to the previous calendar month) |
Downloads/Views of electronic version from website: |
2003 (Figures are cumulative.) Last updated 8th July 2008. |
URL of this page: |
http://www.hta.ac.uk/1432 |
News feeds